| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 3.08e-07 | 4 | 86 | 3 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 3.08e-07 | 4 | 86 | 3 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 3.08e-07 | 4 | 86 | 3 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 7.67e-07 | 5 | 86 | 3 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 7.67e-07 | 5 | 86 | 3 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 7.67e-07 | 5 | 86 | 3 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 7.67e-07 | 5 | 86 | 3 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 7.67e-07 | 5 | 86 | 3 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 7.67e-07 | 5 | 86 | 3 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 7.67e-07 | 5 | 86 | 3 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.53e-06 | 6 | 86 | 3 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 2.67e-06 | 7 | 86 | 3 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 4.25e-06 | 8 | 86 | 3 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 4.25e-06 | 8 | 86 | 3 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 4.25e-06 | 8 | 86 | 3 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 6.36e-06 | 9 | 86 | 3 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 6.36e-06 | 9 | 86 | 3 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 9.06e-06 | 10 | 86 | 3 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 9.06e-06 | 10 | 86 | 3 | GO:0032052 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 2.71e-05 | 14 | 86 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 2.71e-05 | 14 | 86 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 8.34e-05 | 20 | 86 | 3 | GO:0004303 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 1.09e-04 | 4 | 86 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.39e-04 | 115 | 86 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.46e-04 | 24 | 86 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.87e-04 | 26 | 86 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 1.87e-04 | 26 | 86 | 3 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 2.09e-04 | 27 | 86 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 2.88e-04 | 30 | 86 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 3.50e-04 | 32 | 86 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.83e-04 | 33 | 86 | 3 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 4.19e-04 | 34 | 86 | 3 | GO:0016628 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 6.30e-04 | 39 | 86 | 3 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 6.79e-04 | 40 | 86 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 9.83e-04 | 11 | 86 | 2 | GO:0030283 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.16e-03 | 48 | 86 | 3 | GO:0016620 | |
| GeneOntologyMolecularFunction | zinc ion binding | L3MBTL2 DTNA DBF4 ANKIB1 PAPPA PRKCG UPF1 HERC2 FBXL19 ZZEF1 PRDM2 | 1.51e-03 | 891 | 86 | 11 | GO:0008270 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.52e-03 | 194 | 86 | 5 | GO:0016705 | |
| GeneOntologyMolecularFunction | transition metal ion binding | L3MBTL2 DTNA DBF4 CYP19A1 ANKIB1 CYP2U1 PAPPA PRKCG UPF1 HERC2 FBXL19 ZZEF1 PRDM2 | 1.67e-03 | 1189 | 86 | 13 | GO:0046914 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.81e-03 | 56 | 86 | 3 | GO:0016903 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 2.21e-03 | 60 | 86 | 3 | GO:0016655 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.22e-03 | 127 | 86 | 4 | GO:0016616 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 2.43e-03 | 62 | 86 | 3 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 2.43e-03 | 62 | 86 | 3 | GO:0050661 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 2.99e-03 | 138 | 86 | 4 | GO:0016614 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 2.89e-07 | 4 | 87 | 3 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 2.89e-07 | 4 | 87 | 3 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 2.89e-07 | 4 | 87 | 3 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 2.89e-07 | 4 | 87 | 3 | GO:0008208 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 5.17e-07 | 16 | 87 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 7.20e-07 | 5 | 87 | 3 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 7.20e-07 | 5 | 87 | 3 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 7.20e-07 | 5 | 87 | 3 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 7.20e-07 | 5 | 87 | 3 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 7.20e-07 | 5 | 87 | 3 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 7.20e-07 | 5 | 87 | 3 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 1.44e-06 | 6 | 87 | 3 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 1.44e-06 | 6 | 87 | 3 | GO:0016095 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.67e-06 | 21 | 87 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 2.51e-06 | 7 | 87 | 3 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 2.51e-06 | 7 | 87 | 3 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 2.51e-06 | 7 | 87 | 3 | GO:1900052 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 5.98e-06 | 9 | 87 | 3 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 8.51e-06 | 10 | 87 | 3 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 8.51e-06 | 10 | 87 | 3 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 8.51e-06 | 10 | 87 | 3 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 8.51e-06 | 10 | 87 | 3 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 8.51e-06 | 10 | 87 | 3 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.17e-05 | 11 | 87 | 3 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.17e-05 | 11 | 87 | 3 | GO:0016115 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.24e-05 | 34 | 87 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 1.40e-05 | 35 | 87 | 4 | GO:0120255 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 2.55e-05 | 14 | 87 | 3 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 2.55e-05 | 14 | 87 | 3 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 3.18e-05 | 15 | 87 | 3 | GO:0016102 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 3.86e-05 | 45 | 87 | 4 | GO:0008207 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 3.90e-05 | 16 | 87 | 3 | GO:0032351 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 5.65e-05 | 18 | 87 | 3 | GO:0030656 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 9.12e-05 | 21 | 87 | 3 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 9.12e-05 | 21 | 87 | 3 | GO:0048385 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 9.12e-05 | 21 | 87 | 3 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 9.12e-05 | 21 | 87 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 9.83e-05 | 57 | 87 | 4 | GO:0042181 | |
| GeneOntologyBiologicalProcess | parturition | 1.05e-04 | 22 | 87 | 3 | GO:0007567 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 1.05e-04 | 22 | 87 | 3 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 1.05e-04 | 22 | 87 | 3 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 1.05e-04 | 22 | 87 | 3 | GO:1902644 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 1.21e-04 | 23 | 87 | 3 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 1.21e-04 | 23 | 87 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 1.76e-04 | 26 | 87 | 3 | GO:0010566 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 2.17e-04 | 129 | 87 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 2.20e-04 | 28 | 87 | 3 | GO:0048025 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 2.45e-04 | 29 | 87 | 3 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 2.45e-04 | 29 | 87 | 3 | GO:0050686 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 3.29e-04 | 32 | 87 | 3 | GO:2000353 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 3.61e-04 | 33 | 87 | 3 | GO:0033119 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 4.68e-04 | 36 | 87 | 3 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 4.68e-04 | 36 | 87 | 3 | GO:0008299 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 5.50e-04 | 38 | 87 | 3 | GO:0048384 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 5.52e-04 | 158 | 87 | 5 | GO:0050684 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 6.40e-04 | 40 | 87 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 7.39e-04 | 42 | 87 | 3 | GO:0071398 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 7.96e-04 | 358 | 87 | 7 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 7.96e-04 | 358 | 87 | 7 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 8.49e-04 | 362 | 87 | 7 | GO:0000375 | |
| GeneOntologyBiologicalProcess | response to estrogen | 9.50e-04 | 103 | 87 | 4 | GO:0043627 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 9.93e-04 | 180 | 87 | 5 | GO:0120254 | |
| GeneOntologyBiologicalProcess | regulation of G protein-coupled receptor signaling pathway | 1.02e-03 | 181 | 87 | 5 | GO:0008277 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 1.03e-03 | 47 | 87 | 3 | GO:0046164 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 1.06e-03 | 106 | 87 | 4 | GO:0050810 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.65e-03 | 202 | 87 | 5 | GO:0141193 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 1.71e-03 | 56 | 87 | 3 | GO:0006693 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 1.80e-03 | 57 | 87 | 3 | GO:0006692 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.84e-03 | 207 | 87 | 5 | GO:0043484 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 1.89e-03 | 58 | 87 | 3 | GO:0032350 | |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 1.92e-03 | 209 | 87 | 5 | GO:0006694 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 2.09e-03 | 60 | 87 | 3 | GO:1904037 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 2.12e-03 | 128 | 87 | 4 | GO:0033559 | |
| MousePheno | parturition failure | 1.47e-05 | 10 | 71 | 3 | MP:0012010 | |
| MousePheno | hypermyelination | 2.01e-05 | 11 | 71 | 3 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 3.46e-05 | 13 | 71 | 3 | MP:0010160 | |
| MousePheno | long gestation period | 5.47e-05 | 15 | 71 | 3 | MP:0002293 | |
| MousePheno | increased circulating progesterone level | 5.47e-05 | 15 | 71 | 3 | MP:0005186 | |
| MousePheno | long stride length | 5.47e-05 | 15 | 71 | 3 | MP:0010540 | |
| MousePheno | decreased vocalization | 8.49e-05 | 46 | 71 | 4 | MP:0020351 | |
| MousePheno | abnormal gestational length | 9.70e-05 | 18 | 71 | 3 | MP:0002292 | |
| MousePheno | abnormal circulating progesterone level | 1.18e-04 | 50 | 71 | 4 | MP:0005184 | |
| MousePheno | dysmyelination | 1.35e-04 | 20 | 71 | 3 | MP:0013438 | |
| MousePheno | abnormal progesterone level | 1.60e-04 | 54 | 71 | 4 | MP:0011384 | |
| MousePheno | prostate gland dorsolateral lobe hyperplasia | 2.52e-04 | 5 | 71 | 2 | MP:0031369 | |
| MousePheno | prostate gland hyperplasia | 2.52e-04 | 5 | 71 | 2 | MP:0000659 | |
| MousePheno | decreased oligodendrocyte number | 2.67e-04 | 25 | 71 | 3 | MP:0009808 | |
| MousePheno | abnormal coping response | 3.47e-04 | 66 | 71 | 4 | MP:0003062 | |
| MousePheno | prostate gland anterior lobe hyperplasia | 3.77e-04 | 6 | 71 | 2 | MP:0005305 | |
| MousePheno | enlarged prostate gland anterior lobe | 3.77e-04 | 6 | 71 | 2 | MP:0009738 | |
| MousePheno | enlarged prostate gland dorsolateral lobe | 3.77e-04 | 6 | 71 | 2 | MP:0009739 | |
| MousePheno | abnormal ovulation cycle | 4.45e-04 | 126 | 71 | 5 | MP:0009344 | |
| MousePheno | prolonged diestrus | 4.62e-04 | 30 | 71 | 3 | MP:0009011 | |
| MousePheno | abnormal parturition | 6.14e-04 | 33 | 71 | 3 | MP:0002907 | |
| MousePheno | abnormal diestrus | 7.31e-04 | 35 | 71 | 3 | MP:0009010 | |
| MousePheno | abnormal stride length | 7.93e-04 | 82 | 71 | 4 | MP:0012690 | |
| Domain | ALDOKETO_REDUCTASE_1 | 9.93e-06 | 10 | 83 | 3 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 9.93e-06 | 10 | 83 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 9.93e-06 | 10 | 83 | 3 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 9.93e-06 | 10 | 83 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 9.93e-06 | 10 | 83 | 3 | PS00063 | |
| Domain | - | 4.55e-05 | 16 | 83 | 3 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 5.50e-05 | 17 | 83 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 5.50e-05 | 17 | 83 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 5.50e-05 | 17 | 83 | 3 | IPR001395 | |
| Domain | ZZ | 6.58e-05 | 18 | 83 | 3 | PF00569 | |
| Domain | ZF_ZZ_2 | 6.58e-05 | 18 | 83 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 6.58e-05 | 18 | 83 | 3 | PS01357 | |
| Domain | Znf_ZZ | 7.79e-05 | 19 | 83 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 7.79e-05 | 19 | 83 | 3 | SM00291 | |
| Domain | APC_su10/DOC_dom | 4.04e-04 | 7 | 83 | 2 | IPR004939 | |
| Domain | DOC | 4.04e-04 | 7 | 83 | 2 | PS51284 | |
| Domain | APC10 | 4.04e-04 | 7 | 83 | 2 | SM01337 | |
| Domain | ANAPC10 | 4.04e-04 | 7 | 83 | 2 | PF03256 | |
| Domain | ATPase_dyneun-rel_AAA | 1.72e-03 | 14 | 83 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.72e-03 | 14 | 83 | 2 | PF07728 | |
| Domain | Rib_L2_dom2 | 2.85e-03 | 18 | 83 | 2 | IPR014722 | |
| Domain | - | 2.85e-03 | 18 | 83 | 2 | 2.30.30.30 | |
| Domain | PLAC | 3.18e-03 | 19 | 83 | 2 | PS50900 | |
| Domain | PLAC | 3.18e-03 | 19 | 83 | 2 | IPR010909 | |
| Domain | GPCR_3 | 3.88e-03 | 21 | 83 | 2 | IPR000337 | |
| Domain | ARM-type_fold | 4.00e-03 | 339 | 83 | 6 | IPR016024 | |
| Domain | 7tm_3 | 4.25e-03 | 22 | 83 | 2 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 4.25e-03 | 22 | 83 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 4.25e-03 | 22 | 83 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 4.25e-03 | 22 | 83 | 2 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 4.25e-03 | 22 | 83 | 2 | PS50259 | |
| Domain | GPCR_3_C | 4.25e-03 | 22 | 83 | 2 | IPR017978 | |
| Domain | ADAM_spacer1 | 4.65e-03 | 23 | 83 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 4.65e-03 | 23 | 83 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 5.05e-03 | 24 | 83 | 2 | IPR013273 | |
| Domain | MetalloPept_cat_dom | 5.63e-03 | 81 | 83 | 3 | IPR024079 | |
| Domain | - | 5.63e-03 | 81 | 83 | 3 | 3.40.390.10 | |
| Domain | Galactose-bd-like | 8.48e-03 | 94 | 83 | 3 | IPR008979 | |
| Domain | - | 8.73e-03 | 95 | 83 | 3 | 2.60.120.200 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 7.01e-06 | 9 | 63 | 3 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 7.01e-06 | 9 | 63 | 3 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 1.37e-05 | 11 | 63 | 3 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 2.36e-05 | 13 | 63 | 3 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 2.36e-05 | 13 | 63 | 3 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 2.99e-05 | 14 | 63 | 3 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 2.99e-05 | 14 | 63 | 3 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 2.99e-05 | 14 | 63 | 3 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 2.99e-05 | 14 | 63 | 3 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 3.73e-05 | 15 | 63 | 3 | MM14870 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.04e-04 | 55 | 63 | 4 | M14933 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.41e-04 | 23 | 63 | 3 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.41e-04 | 23 | 63 | 3 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.41e-04 | 23 | 63 | 3 | MM14741 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.56e-04 | 61 | 63 | 4 | MM14861 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 2.57e-04 | 28 | 63 | 3 | MM15188 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 4.22e-04 | 33 | 63 | 3 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 4.22e-04 | 33 | 63 | 3 | MM14737 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 7.54e-04 | 92 | 63 | 4 | MM14881 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 9.89e-04 | 44 | 63 | 3 | M499 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 1.06e-03 | 45 | 63 | 3 | M39355 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.06e-03 | 45 | 63 | 3 | MM15344 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.06e-03 | 45 | 63 | 3 | MM14751 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 1.57e-08 | 3 | 88 | 3 | 31780644 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 21232532 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 13678667 | ||
| Pubmed | GPRASP1 DNAJC13 DSTN GPR158 NSF N4BP2 SPTAN1 PRKCG UPF1 HERC2 BCOR GRM5 DNAJA1 TOP3B DYNC1H1 | 1.87e-08 | 963 | 88 | 15 | 28671696 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DNAJC13 DSTN SPOUT1 L3MBTL2 UPF2 CEBPZ SPTAN1 CTNNBL1 ANKIB1 PDCD11 DDX20 UPF1 HERC2 DNAJA1 MAP2K3 ELAC2 DYNC1H1 | 4.36e-08 | 1353 | 88 | 17 | 29467282 |
| Pubmed | SPOUT1 UPF2 VWA8 CEBPZ SPTAN1 CTNNBL1 AKR1C3 PDCD11 ISG20L2 DDX20 UPF1 HERC2 PIPSL AKR1C1 AKR1C2 BDH1 DYNC1H1 | 5.27e-08 | 1371 | 88 | 17 | 36244648 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 20124700 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 6.25e-08 | 4 | 88 | 3 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 6.25e-08 | 4 | 88 | 3 | 16508162 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 6.25e-08 | 4 | 88 | 3 | 14967952 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 6.25e-08 | 4 | 88 | 3 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 6.25e-08 | 4 | 88 | 3 | 31479646 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 15222881 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 16191478 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 15577209 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 10702227 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 17034817 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 17629694 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 6.25e-08 | 4 | 88 | 3 | 29764944 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 10526179 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 17888864 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 17442338 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 28329705 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 16018803 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 17272929 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 6.25e-08 | 4 | 88 | 3 | 18667791 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 28259989 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 21521174 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 8274401 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 16511129 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 6.25e-08 | 4 | 88 | 3 | 34590152 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 7789999 | ||
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 7737980 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 1.56e-07 | 5 | 88 | 3 | 21851338 | |
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 1.56e-07 | 5 | 88 | 3 | 17064890 | |
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 10672042 | ||
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 38788959 | ||
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 15212687 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 1.56e-07 | 5 | 88 | 3 | 16984997 | |
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 18003893 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 3.11e-07 | 6 | 88 | 3 | 29107092 | |
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 19273550 | ||
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 15860270 | ||
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 3.11e-07 | 6 | 88 | 3 | 26748576 | |
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 3.11e-07 | 6 | 88 | 3 | 17255200 | |
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 5.44e-07 | 7 | 88 | 3 | 34843575 | |
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 22529366 | ||
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 33127481 | ||
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 19846565 | ||
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 12562828 | ||
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 16337335 | ||
| Pubmed | 6.42e-07 | 27 | 88 | 4 | 17077188 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KIAA0930 KMT2D SPOUT1 VWA8 TXNRD3 PDCD11 EXOSC8 HERC2 FBXL19 ZZEF1 TOP3B ELAC2 DYNC1H1 RIC1 | 7.10e-07 | 1105 | 88 | 14 | 35748872 |
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 33584538 | ||
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 20837989 | ||
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 9224647 | ||
| Pubmed | MET DNAJC13 L3MBTL2 VWA8 NSF CEBPZ DTNA N4BP2 SPTAN1 PDCD11 EXOSC8 UPF1 HERC2 DNAJA1 TOP3B ELAC2 | 9.08e-07 | 1487 | 88 | 16 | 33957083 | |
| Pubmed | 1.30e-06 | 9 | 88 | 3 | 33348080 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 1.85e-06 | 10 | 88 | 3 | 36313771 | |
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 3.39e-06 | 12 | 88 | 3 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 3.39e-06 | 12 | 88 | 3 | 28893949 | |
| Pubmed | 3.39e-06 | 12 | 88 | 3 | 25774556 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DNAJC13 SPOUT1 UPF2 CEBPZ PDCD11 EXOSC8 ISG20L2 UPF1 HERC2 DNAJA1 TOP3B | 3.46e-06 | 759 | 88 | 11 | 35915203 |
| Pubmed | 4.40e-06 | 13 | 88 | 3 | 11682476 | ||
| Pubmed | 4.40e-06 | 13 | 88 | 3 | 17062636 | ||
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 4.40e-06 | 13 | 88 | 3 | 17761849 | |
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 4.40e-06 | 13 | 88 | 3 | 15117747 | |
| Pubmed | 4.40e-06 | 13 | 88 | 3 | 24580729 | ||
| Pubmed | 5.58e-06 | 14 | 88 | 3 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 5.58e-06 | 14 | 88 | 3 | 34400844 | |
| Pubmed | Modulation of RNA-binding properties of the RNA helicase UPF1 by its activator UPF2. | 6.33e-06 | 2 | 88 | 2 | 36456182 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 8573067 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 26719224 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 11514561 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 15492289 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 19556890 | ||
| Pubmed | Local androgen inactivation in abdominal visceral adipose tissue. | 6.33e-06 | 2 | 88 | 2 | 14671194 | |
| Pubmed | MACC1 is related to colorectal cancer initiation and early-stage invasive growth. | 6.33e-06 | 2 | 88 | 2 | 24124150 | |
| Pubmed | MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. | 6.33e-06 | 2 | 88 | 2 | 22179665 | |
| Pubmed | Unusual bipartite mode of interaction between the nonsense-mediated decay factors, UPF1 and UPF2. | 6.33e-06 | 2 | 88 | 2 | 19556969 | |
| Pubmed | Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy. | 6.33e-06 | 2 | 88 | 2 | 22493396 | |
| Pubmed | AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer. | 6.33e-06 | 2 | 88 | 2 | 16338060 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 23165153 | ||
| Pubmed | Prognostic value and clinical pathology of MACC-1 and c-MET expression in gastric carcinoma. | 6.33e-06 | 2 | 88 | 2 | 23812675 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 33675863 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 34830394 | ||
| Pubmed | Molecular mechanisms for the RNA-dependent ATPase activity of Upf1 and its regulation by Upf2. | 6.33e-06 | 2 | 88 | 2 | 21419344 | |
| Pubmed | cDNA and deduced amino acid sequences of a human colon dihydrodiol dehydrogenase. | 6.33e-06 | 2 | 88 | 2 | 8011662 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 18654764 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 30367463 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 21217827 | ||
| Interaction | AKR1C4 interactions | 4.28e-06 | 8 | 87 | 3 | int:AKR1C4 | |
| Interaction | LSM1 interactions | 6.56e-06 | 106 | 87 | 6 | int:LSM1 | |
| Interaction | TOP3B interactions | KIAA0930 KMT2D SPOUT1 UPF2 VWA8 SPTAN1 TXNRD3 PDCD11 EXOSC8 DDX20 UPF1 HERC2 FBXL19 ZZEF1 DNAJA1 TOP3B ELAC2 DYNC1H1 RIC1 | 1.29e-05 | 1470 | 87 | 19 | int:TOP3B |
| Interaction | AKR1C3 interactions | 1.92e-05 | 37 | 87 | 4 | int:AKR1C3 | |
| Interaction | FOXL1 interactions | 2.24e-05 | 196 | 87 | 7 | int:FOXL1 | |
| Interaction | DNA2 interactions | 2.34e-05 | 79 | 87 | 5 | int:DNA2 | |
| Interaction | HDAC11 interactions | 5.48e-05 | 154 | 87 | 6 | int:HDAC11 | |
| Cytoband | 10p15-p14 | 1.36e-07 | 6 | 88 | 3 | 10p15-p14 | |
| GeneFamily | Aldo-keto reductases | 1.78e-05 | 15 | 63 | 3 | 399 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.17e-05 | 18 | 63 | 3 | 91 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.97e-03 | 19 | 63 | 2 | 50 | |
| Coexpression | CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP | 1.34e-06 | 239 | 87 | 8 | M4716 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 6.88e-06 | 37 | 87 | 4 | MM630 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | 1.59e-05 | 335 | 87 | 8 | M39065 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CELF5 GPRASP1 GPR158 N4BP2 GLRA2 ANKIB1 PAPPA SERINC5 GRM5 MAP2K3 AKR1C1 AKR1C2 PRDM2 TTLL7 | 1.59e-05 | 1106 | 87 | 14 | M39071 |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 2.32e-05 | 17 | 87 | 3 | MM826 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 4.16e-05 | 190 | 87 | 6 | MM1311 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | CELF5 GPRASP1 LRRTM4 PAPPA GRM5 FKBP1B AKR1C1 AKR1C2 B4GALT6 | 5.21e-05 | 513 | 87 | 9 | M39069 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL | 5.48e-05 | 122 | 87 | 5 | M45802 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKTCELL_DN | 5.53e-05 | 200 | 87 | 6 | M4788 | |
| Coexpression | BILBAN_B_CLL_LPL_UP | 6.18e-05 | 64 | 87 | 4 | M19930 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 6.80e-05 | 24 | 87 | 3 | MM766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 7.71e-05 | 25 | 87 | 3 | MM480 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 8.30e-05 | 69 | 87 | 4 | MM621 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 1.14e-04 | 228 | 87 | 6 | MM1014 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 1.34e-04 | 30 | 87 | 3 | MM853 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | CELF5 GPRASP1 GLRA2 LRRTM4 PAPPA CADPS2 FKBP1B AKR1C1 AKR1C2 | 1.39e-04 | 584 | 87 | 9 | M39068 |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 1.41e-04 | 79 | 87 | 4 | MM535 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 183 | 88 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-06 | 191 | 88 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 2.47e-05 | 174 | 88 | 5 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 2.61e-05 | 176 | 88 | 5 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.75e-05 | 178 | 88 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 181 | 88 | 5 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 182 | 88 | 5 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 183 | 88 | 5 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 183 | 88 | 5 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 186 | 88 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 186 | 88 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 3.48e-05 | 187 | 88 | 5 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 188 | 88 | 5 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.57e-05 | 188 | 88 | 5 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-05 | 189 | 88 | 5 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-05 | 189 | 88 | 5 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 3.66e-05 | 189 | 88 | 5 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-05 | 190 | 88 | 5 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-05 | 190 | 88 | 5 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.76e-05 | 190 | 88 | 5 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 3.76e-05 | 190 | 88 | 5 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-05 | 191 | 88 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 3.85e-05 | 191 | 88 | 5 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 193 | 88 | 5 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.15e-05 | 194 | 88 | 5 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.15e-05 | 194 | 88 | 5 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-05 | 194 | 88 | 5 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.36e-05 | 196 | 88 | 5 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.36e-05 | 196 | 88 | 5 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-F|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.46e-05 | 197 | 88 | 5 | fbff2fb7a8142b88c9dc71aa10980f4350b7e081 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-D|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.57e-05 | 198 | 88 | 5 | fd14efd8e6c74a04bde985c08dc34217c0ef1bab | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-05 | 198 | 88 | 5 | be305d89d48c67ce922fa71aaf15e24d00c89ff6 | |
| ToppCell | NS-moderate-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.68e-05 | 199 | 88 | 5 | aa2b51940115c22768c0d7493b4b60d41df3f376 | |
| ToppCell | moderate-Epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.79e-05 | 200 | 88 | 5 | 095783c9b75113ae350c2d5fb1195d71b41fa695 | |
| ToppCell | NS-moderate-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.79e-05 | 200 | 88 | 5 | 85940b4bf7971b872469dea8b8d7a45bdeb2a909 | |
| ToppCell | Severe-Epithelial-Epithelial-|Severe / Condition, Lineage, Cell class and cell subclass | 4.79e-05 | 200 | 88 | 5 | 8669ce08f93eefb8ac970e30cdc4b1f908023c54 | |
| ToppCell | Severe-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 4.79e-05 | 200 | 88 | 5 | 6ead9db88568bb829d564a6d8e85f71fd765bac0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.79e-05 | 200 | 88 | 5 | 9b5753726c17dda98d7384a60f26a5eaf4f6c4d6 | |
| ToppCell | Severe-Epithelial-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 4.79e-05 | 200 | 88 | 5 | 3bd1ce2793651c9badd69f011d2531183594e5f4 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 4.79e-05 | 200 | 88 | 5 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 4.79e-05 | 200 | 88 | 5 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(4)_1wkpi|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 1.01e-04 | 122 | 88 | 4 | b2a070939c0660c82a1130ef423fd627e9e087ab | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 140 | 88 | 4 | 7ca49bd7ba9381e75c10f888775df17e5d46804d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 140 | 88 | 4 | 1a31bc33d5723b9bc528cc0047ca5f4c80531c7a | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.90e-04 | 144 | 88 | 4 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-5|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.65e-04 | 157 | 88 | 4 | 59450e9f580555091b159fbbe0a0756e51bcd9ad | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-04 | 66 | 88 | 3 | 57fd31a25addc48793d7975eadccf4c5a41a8b03 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8-Tnaive/CM_CD8|Lung / Manually curated celltypes from each tissue | 3.06e-04 | 163 | 88 | 4 | c8e4440d1a857e4da83002303940dd42b273c92e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-04 | 164 | 88 | 4 | 54f8f11d2fa899005530c08e7a1ee728c7b0799c | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.27e-04 | 166 | 88 | 4 | 8de8f388f24436b84e19ef460476fdbda4d16abf | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-04 | 166 | 88 | 4 | 9e98e6070055bfc780becee52d77830e06b6d854 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-04 | 166 | 88 | 4 | 8d5d09f25e8903d481c2097fed435e69d42ccdb5 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 167 | 88 | 4 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9 | 3.43e-04 | 168 | 88 | 4 | b427746929bb40e3d1b5f1c40d302b792d6b32a5 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.43e-04 | 168 | 88 | 4 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 169 | 88 | 4 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-04 | 170 | 88 | 4 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 172 | 88 | 4 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 172 | 88 | 4 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 3.83e-04 | 173 | 88 | 4 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-04 | 174 | 88 | 4 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.08e-04 | 176 | 88 | 4 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.08e-04 | 176 | 88 | 4 | 91ad2c34144f72283ca112fd3b3784f2f6259f65 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-04 | 176 | 88 | 4 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-04 | 177 | 88 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-04 | 177 | 88 | 4 | 2dd6dd5193bda9ba1c6b299ec47890fdc92f88b1 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.17e-04 | 177 | 88 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 179 | 88 | 4 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-04 | 180 | 88 | 4 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.45e-04 | 180 | 88 | 4 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-04 | 180 | 88 | 4 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.54e-04 | 181 | 88 | 4 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-04 | 181 | 88 | 4 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-04 | 181 | 88 | 4 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-04 | 182 | 88 | 4 | dfde2d9950f445c6c936ac828f7210de87bb45ec | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-04 | 182 | 88 | 4 | c6172aca2475bf0948a78e39f0dae6388504a915 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-04 | 182 | 88 | 4 | 52274af3136d4fd4a495f5882618444661421f0f | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-04 | 183 | 88 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 183 | 88 | 4 | f3728b1a51951c7349f77a3e4d2671ca3a8d2a44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-04 | 184 | 88 | 4 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.83e-04 | 184 | 88 | 4 | d48807f9da48bdd015a54c606d2e2a311f181396 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 184 | 88 | 4 | 8939b6d795992775df0ff58ed1ec9d421a00bcc4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.93e-04 | 185 | 88 | 4 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 4.93e-04 | 185 | 88 | 4 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-04 | 186 | 88 | 4 | aeac0c2db173cd1ea45b5052ab418d6cacd198d8 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 5.03e-04 | 186 | 88 | 4 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-04 | 186 | 88 | 4 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-04 | 186 | 88 | 4 | bcb3ac9f9b51346e0a2b0bda96d149b3c11f7883 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-04 | 187 | 88 | 4 | 028e7d6e1211e123879d2f353dc32fae1185dd8e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-04 | 187 | 88 | 4 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-04 | 187 | 88 | 4 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-04 | 187 | 88 | 4 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.24e-04 | 188 | 88 | 4 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.24e-04 | 188 | 88 | 4 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-04 | 188 | 88 | 4 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-04 | 189 | 88 | 4 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-04 | 189 | 88 | 4 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.34e-04 | 189 | 88 | 4 | 0739baad9a7da511dd3d7249f84299aee88370a1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-04 | 189 | 88 | 4 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-04 | 189 | 88 | 4 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| Drug | cyclopentanol | 5.20e-08 | 3 | 86 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 5.20e-08 | 3 | 86 | 3 | ctd:C007201 | |
| Drug | 4-benzoylbenzoic acid | 5.20e-08 | 3 | 86 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 5.20e-08 | 3 | 86 | 3 | ctd:C530610 | |
| Drug | cloxazolam | 2.08e-07 | 4 | 86 | 3 | ctd:C005522 | |
| Drug | Pregnanes | 2.08e-07 | 4 | 86 | 3 | ctd:D011278 | |
| Drug | tetralol | 2.08e-07 | 4 | 86 | 3 | ctd:C019106 | |
| Drug | gliquidone | 2.08e-07 | 4 | 86 | 3 | ctd:C010969 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 2.08e-07 | 4 | 86 | 3 | ctd:C018156 | |
| Drug | Hydroxysteroids | 5.17e-07 | 5 | 86 | 3 | ctd:D006914 | |
| Drug | NSC86000 | 5.17e-07 | 5 | 86 | 3 | CID000257630 | |
| Drug | cresolphthalein | 5.17e-07 | 5 | 86 | 3 | ctd:C010092 | |
| Drug | oxcarbazepine | 7.04e-07 | 19 | 86 | 4 | ctd:C036006 | |
| Drug | Estazolam | 1.03e-06 | 6 | 86 | 3 | ctd:D004949 | |
| Drug | Glipizide | 1.03e-06 | 6 | 86 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 1.03e-06 | 6 | 86 | 3 | ctd:C023723 | |
| Drug | Medazepam | 1.03e-06 | 6 | 86 | 3 | ctd:D008472 | |
| Drug | androstane-3,17-dione | 1.40e-06 | 51 | 86 | 5 | CID000000443 | |
| Drug | 4-hydroxyequilenin-o-quinone | 1.80e-06 | 7 | 86 | 3 | ctd:C117714 | |
| Drug | zomepirac | 1.80e-06 | 7 | 86 | 3 | ctd:C020549 | |
| Drug | 1,2-dihydroxynaphthalene | 2.45e-06 | 57 | 86 | 5 | CID000011318 | |
| Drug | Nitrazepam | 2.87e-06 | 8 | 86 | 3 | ctd:D009567 | |
| Drug | UDP-FGlc | 3.73e-06 | 62 | 86 | 5 | CID000125643 | |
| Drug | 4-hydroxybenzoic acid | 4.30e-06 | 9 | 86 | 3 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 4.30e-06 | 9 | 86 | 3 | ctd:D004092 | |
| Drug | octyl gallate | 6.13e-06 | 10 | 86 | 3 | ctd:C016627 | |
| Drug | Dihydroxydihydrobenzopyrenes | 8.40e-06 | 11 | 86 | 3 | ctd:D004101 | |
| Drug | 7-hydroxyflavone | 8.40e-06 | 11 | 86 | 3 | ctd:C429845 | |
| Drug | chlordecone alcohol | 8.40e-06 | 11 | 86 | 3 | CID000013946 | |
| Drug | indomethacin, USP; Down 200; 100uM; MCF7; HG-U133A | 1.02e-05 | 198 | 86 | 7 | 453_DN | |
| Drug | fenamic acid | 1.12e-05 | 12 | 86 | 3 | ctd:C001209 | |
| Drug | Phenolphthalein | 1.12e-05 | 12 | 86 | 3 | ctd:D020113 | |
| Drug | alpha-methylcinnamic acid | 1.41e-05 | 2 | 86 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 1.41e-05 | 2 | 86 | 2 | DB07768 | |
| Drug | baccharin | 1.41e-05 | 2 | 86 | 2 | ctd:C012764 | |
| Drug | DMBA-3,4-dihydrodiol | 1.45e-05 | 13 | 86 | 3 | CID000050096 | |
| Drug | flunisolide | 1.45e-05 | 13 | 86 | 3 | ctd:C007734 | |
| Drug | 20 alpha-dihydroprogesterone | 1.56e-05 | 40 | 86 | 4 | CID000008956 | |
| Drug | Dydrogesterone | 1.84e-05 | 14 | 86 | 3 | ctd:D004394 | |
| Drug | 5-alpha-Dihydroprogesterone | 1.84e-05 | 14 | 86 | 3 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 1.84e-05 | 14 | 86 | 3 | CID000022750 | |
| Drug | Meclofenamic Acid | 1.84e-05 | 14 | 86 | 3 | ctd:D008469 | |
| Drug | naphthalene-1,2-dihydrodiol | 2.51e-05 | 45 | 86 | 4 | CID000000362 | |
| Drug | phorbol 12,13-diacetate | 3.25e-05 | 48 | 86 | 4 | CID000072293 | |
| Drug | benzo(a)pyrene-1,6-quinone | 3.41e-05 | 17 | 86 | 3 | ctd:C030233 | |
| Drug | cloxazolam | 4.08e-05 | 18 | 86 | 3 | CID000002816 | |
| Drug | Ruthenium Compounds | 4.08e-05 | 18 | 86 | 3 | ctd:D017975 | |
| Drug | benzo(a)pyrene-3,6-quinone | 4.08e-05 | 18 | 86 | 3 | ctd:C018003 | |
| Drug | MoF4 | 4.22e-05 | 3 | 86 | 2 | CID000141030 | |
| Drug | 5-dihydrodeoxycorticosterone | 4.22e-05 | 3 | 86 | 2 | ctd:C454687 | |
| Drug | benzo(a)pyrene-7,8-dione | 5.66e-05 | 20 | 86 | 3 | ctd:C076588 | |
| Drug | Chrysenes | 5.66e-05 | 20 | 86 | 3 | ctd:D002911 | |
| Drug | Flunitrazepam | 6.59e-05 | 21 | 86 | 3 | ctd:D005445 | |
| Drug | coniferaldehyde | 6.59e-05 | 21 | 86 | 3 | ctd:C075384 | |
| Drug | Dutasteride | 6.59e-05 | 21 | 86 | 3 | ctd:D000068538 | |
| Drug | NSC36919 | 6.89e-05 | 58 | 86 | 4 | CID000235496 | |
| Drug | benzene dihydrodiol | 7.61e-05 | 22 | 86 | 3 | CID000000418 | |
| Drug | tetrahydrodeoxycorticosterone | 8.42e-05 | 4 | 86 | 2 | ctd:C009413 | |
| Drug | DBD-H | 8.42e-05 | 4 | 86 | 2 | CID000131382 | |
| Drug | thapsigargin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.43e-05 | 190 | 86 | 6 | 7053_DN | |
| Drug | 2'-Monophosphoadenosine 5'-Diphosphoribose | 8.72e-05 | 23 | 86 | 3 | DB03461 | |
| Drug | medazepam | 9.94e-05 | 24 | 86 | 3 | CID000004041 | |
| Drug | 1-chloro-1,2,2-trifluorocyclobutane | 9.94e-05 | 24 | 86 | 3 | CID000079091 | |
| Drug | Glycyrrhetinic Acid | 9.94e-05 | 24 | 86 | 3 | ctd:D006034 | |
| Drug | Myricetin [529-44-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 86 | 6 | 3270_UP | |
| Drug | clofibrate; Up 200; 100uM; MCF7; HG-U133A | 1.09e-04 | 199 | 86 | 6 | 444_UP | |
| Drug | 9,10-phenanthrenequinone | 1.13e-04 | 25 | 86 | 3 | ctd:C005399 | |
| Drug | Pregnanolone | 1.13e-04 | 25 | 86 | 3 | ctd:D011280 | |
| Drug | PEt3 | 1.27e-04 | 26 | 86 | 3 | CID000027365 | |
| Drug | farnesal | 1.40e-04 | 5 | 86 | 2 | ctd:C084519 | |
| Drug | dienogest | 1.43e-04 | 27 | 86 | 3 | ctd:C023635 | |
| Drug | 5 beta-pregnane-3,20-dione | 1.60e-04 | 72 | 86 | 4 | CID000092745 | |
| Drug | AC1L93E5 | 2.09e-04 | 6 | 86 | 2 | CID000412383 | |
| Drug | 3-hydroxyhexobarbital | 2.09e-04 | 6 | 86 | 2 | CID000439898 | |
| Drug | AC1O43OJ | 2.09e-04 | 6 | 86 | 2 | CID006323224 | |
| Drug | pivalaldehyde | 2.09e-04 | 6 | 86 | 2 | CID000012417 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 2.17e-04 | 31 | 86 | 3 | ctd:C017228 | |
| Drug | NAD | 2.41e-04 | 80 | 86 | 4 | ctd:D009243 | |
| Drug | NSC759587 | 2.76e-04 | 444 | 86 | 8 | CID000003816 | |
| Drug | estazolam | 3.12e-04 | 35 | 86 | 3 | CID000003261 | |
| Disease | Neoplasms, Hormone-Dependent | 2.23e-08 | 3 | 84 | 3 | C0027661 | |
| Disease | Ambiguous Genitalia | 2.22e-07 | 5 | 84 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 2.22e-07 | 5 | 84 | 3 | C0033804 | |
| Disease | Hermaphroditism | 2.22e-07 | 5 | 84 | 3 | C0019269 | |
| Disease | Intersex Conditions | 2.22e-07 | 5 | 84 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 2.22e-07 | 5 | 84 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 7.73e-07 | 7 | 84 | 3 | C0036875 | |
| Disease | Endometrioma | 9.91e-05 | 161 | 84 | 5 | C0269102 | |
| Disease | Endometriosis | 9.91e-05 | 161 | 84 | 5 | C0014175 | |
| Disease | cortolone glucuronide (1) measurement | 1.19e-04 | 6 | 84 | 2 | EFO_0800552 | |
| Disease | functional impairment measurement | 1.67e-04 | 7 | 84 | 2 | EFO_0005412 | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 3.55e-04 | 10 | 84 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | Mental Retardation, Psychosocial | 6.80e-04 | 139 | 84 | 4 | C0025363 | |
| Disease | Profound Mental Retardation | 6.80e-04 | 139 | 84 | 4 | C0020796 | |
| Disease | Mental deficiency | 6.80e-04 | 139 | 84 | 4 | C0917816 | |
| Disease | serum IgG glycosylation measurement | 7.37e-04 | 523 | 84 | 7 | EFO_0005193 | |
| Disease | Sclerocystic Ovaries | 7.76e-04 | 144 | 84 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 7.76e-04 | 144 | 84 | 4 | C0032460 | |
| Disease | response to methotrexate | 9.36e-04 | 16 | 84 | 2 | GO_0031427 | |
| Disease | skin pigmentation | 1.02e-03 | 69 | 84 | 3 | EFO_0003784 | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 1.62e-03 | 21 | 84 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | total blood protein measurement | 1.80e-03 | 449 | 84 | 6 | EFO_0004536 | |
| Disease | hair colour measurement | 1.87e-03 | 615 | 84 | 7 | EFO_0007822 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 1.95e-03 | 23 | 84 | 2 | C1708353 | |
| Disease | Periodontal Pocket | 2.30e-03 | 25 | 84 | 2 | EFO_1001393 | |
| Disease | major depressive disorder, COVID-19 | 2.49e-03 | 26 | 84 | 2 | MONDO_0002009, MONDO_0100096 | |
| Disease | sunburn | 2.63e-03 | 96 | 84 | 3 | EFO_0003958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSVLLKCPKPMEENH | 441 | O00472 | |
| VVTGKDCPHMKEKGA | 616 | Q92556 | |
| MIGPEGTDNCHKFVD | 361 | Q8WYA6 | |
| TVKHEQKMDCGGGYI | 96 | Q96L12 | |
| MFGPDICGFDIKKVH | 131 | Q96L12 | |
| LVFAGCLMKDKGHDG | 81 | Q02338 | |
| QCVKLNDGHFMPVLG | 6 | P42330 | |
| EKICAMEGLPQKHNF | 96 | P43652 | |
| GMLVCTGEPQDKHKF | 836 | Q6TFL3 | |
| GMKACVELLVKHGGD | 156 | Q9P2G1 | |
| KMEGLECHVFIGGTP | 156 | Q9UHI6 | |
| DPFKHFVGMLPEKDC | 66 | P60981 | |
| KHGDIKCVLNEGMPI | 296 | P31689 | |
| REGGHPATKDSEMCK | 1031 | Q6W2J9 | |
| GGNNIKKVMEETGCH | 151 | Q9H694 | |
| KKVMEETGCHIHFPD | 156 | Q9H694 | |
| CDFKNMDSLPSGKIH | 561 | Q9UBU7 | |
| NGTHKVMPAKACAGD | 941 | Q8WXS8 | |
| ETKFMPAAEGTICGH | 551 | Q8TE57 | |
| ICNEIVHPGCLKMGK | 116 | Q6PCT2 | |
| GQKCVPGHFGEKLAM | 666 | Q8IZ41 | |
| MKGTPHFKEEQCAPA | 116 | Q4ADV7 | |
| MDEEGKLCCLHKPGG | 226 | Q96B26 | |
| IKHPECSTMSGGKAI | 211 | Q9H4B0 | |
| HKSEIECFTPKGSMG | 886 | P41594 | |
| GNKESTMICAGPKHI | 331 | Q86VH4 | |
| TMICAGPKHIQGEKV | 336 | Q86VH4 | |
| EKNLPEFAKMVCHGE | 221 | Q8IXH7 | |
| CPNHGFKVGMKLEAV | 531 | Q969R5 | |
| HLNNSECMPIKGLGF | 331 | Q5T848 | |
| DGKLGHFSRMNCDKP | 3076 | O95714 | |
| EFVRMKGPQGKGHAE | 241 | Q6ICG6 | |
| RGMKNEEHCPGSFFL | 76 | Q4VX62 | |
| VGGEAMFCDFPKINH | 16 | P36980 | |
| AIDCEMVGTGPKGHV | 181 | Q9H9L3 | |
| EQMGCKHVKGILLYG | 246 | P46459 | |
| EGHIKITDFGMCKEN | 491 | P05129 | |
| PAFVKKQHNGVCDMD | 446 | Q13219 | |
| AKGHCPFMLSELQDG | 66 | P22557 | |
| HTVQPKGKITFCMGI | 561 | A2A3N6 | |
| LEQAFKGGCKAPHAM | 121 | Q86XN7 | |
| VGDHCQLGPVVMCKK | 671 | Q92900 | |
| VKAEMQKHGEDPFCP | 206 | Q7Z449 | |
| GCGEMPRHFAAKLDK | 241 | Q9UBX8 | |
| FGSKLGLQCIGMHEK | 116 | P11511 | |
| FPKKGQTCVVHYTGM | 16 | P68106 | |
| EGKICHGGIDPAFAM | 456 | P51841 | |
| VLKDPYTGMHKGCAF | 76 | Q8N6W0 | |
| ELCPGGNLMHKIYEK | 141 | P57058 | |
| KFVGQCIKEELMHGE | 166 | Q9NWK9 | |
| QKHGMDEFISANPCK | 626 | Q86UW7 | |
| GNRDVCVKMTPTHKG | 326 | O75165 | |
| TEMVCLHSLGKEGPF | 306 | Q6ZN28 | |
| GMGHCLQVKDGTAVK | 376 | P23416 | |
| PEGHGKISVFAVKMA | 121 | Q9Y4J8 | |
| CKVDGHKDIQMPDGI | 4286 | Q14204 | |
| DKEHTPKLMGFCGDL | 211 | Q5T7M9 | |
| PGHGSFVNCGMKKEV | 201 | Q5T280 | |
| CKHPNMKGVVSGEVE | 411 | Q03701 | |
| TKCGKGVDNMPELHK | 1336 | Q13029 | |
| MIKGGGLKHVPCVED | 1096 | Q9HAU5 | |
| VLINKEGHVKMCDFG | 196 | P46734 | |
| PKEAASLFCEMFGGK | 1071 | Q5JY77 | |
| TLKCTVGPAMNKHFN | 621 | P08581 | |
| EKDTFALKPMNCPGH | 481 | A2RTX5 | |
| LFDGLMISCKPNHGQ | 461 | Q07890 | |
| CGEKGPEMFCKLVEH | 41 | P25391 | |
| KEVHKCGFLPGNEKV | 86 | Q9UL46 | |
| FAFLHCKKLVENGGM | 621 | O00267 | |
| QCVKLNDGHFMPVLG | 6 | Q04828 | |
| QCVKLNDGHFMPVLG | 6 | P52895 | |
| DAVLPVMNKAHGGEK | 131 | O95985 | |
| GVVDFMHLDPKKAGT | 306 | Q14690 | |
| EKVGVAFDHMKVCFG | 741 | Q9BQ52 | |
| CVSHMKPYVDGKGRE | 2441 | Q13813 | |
| IPFFEDMCKGIKAGD | 66 | Q86VE9 | |
| VMGVKCEQELGFKGH | 226 | Q7Z5U6 | |
| QKTKMDCTPEKGHTF | 36 | A0A0A0MS06 | |
| KGHQRILMGEKPYEC | 506 | Q5TYW1 | |
| QLVGDCLMKAHQGKG | 1941 | O43149 | |
| GTCVNVGCIPKKLMH | 201 | Q86VQ6 | |
| CPKIVEPHGKMFNEQ | 206 | O15535 | |
| QSHMVKDICLIGGKG | 436 | A3KMH1 | |
| HPSCGKNLGMKSTVE | 206 | Q96NJ3 | |
| NHFPGMGEICRKDFL | 96 | Q6ZT98 | |
| LHECGKCGKAFMPQL | 306 | Q9Y473 | |
| KEMIVKCFEGEGGHS | 276 | Q9NUA8 | |
| KGHQRILMGEKPYEC | 266 | Q4V348 | |
| LKGEGGVEHMECEIK | 1651 | O14686 | |
| VSCGKFMQDPSLVGH | 1436 | Q86UW6 | |
| GQTPEGKGFVEMLCK | 146 | Q9HD90 |